Some patients with hepatitis B faring better after liver transplant
Treatment to reduce recurrence of hepatitis B appears to improve liver transplant outcomes for some patients, according to a Mayo Clinic study presented at the American Transplant Congress under way May 1-5 in San Diego. "We found that in patients with hepatitis B, the number of patients who were listed for a second transplant within three years decreased by 50 percent between 1996 and 2005," says Ray Kim, M.D., the senior investigator of the research team.
Hepatitis B infection is a major cause of liver damage that can eventually lead to end-stage liver disease and the need for a liver transplant. In the past, hepatitis B recurred in some transplant patients, causing liver damage and the need for a second transplant.
"In the past 10 years, new medications have improved our ability to control hepatitis B," says Dr. Kim. Today, transplant recipients routinely are treated with antiviral therapy and hepatitis B immune globulin to reduce the risk of recurrence. "We wanted to know if the medication protocols were making a difference in patient outcomes," he says.
Researchers reviewed data provided by the Organ Procurement and Transplantation Network of 31,242 liver transplants in the United States. The underlying reasons for transplantation were categorized as hepatitis B, hepatitis C or other.
From 1996 to 1998, 6.5 percent of liver transplant patients with hepatitis B were listed for a second transplant. For 2003 to 2005, the number of liver transplant patients with hepatitis B listed for a second transplant was 3.3 percent -- roughly a 50 percent reduction.
For patients with hepatitis C or other underlying liver disease, there were smaller declines in relisting numbers. Preventing recurrence of hepatitis C has proved to be more challenging than preventing recurrence of hepatitis B, says Dr. Kim.
Over the same periods, mortality rates increased for all three groups. For patients with hepatitis B, the death rate was 10.8 percent from 1996 to 1998. The rate increased to 12.8 percent for 2003 to 2005.
"Our results show that transplant outcome is consistently improving for patients with hepatitis B with a significant decrease in need for second transplants," says Dr. Kim. "The increases in mortality rates are concerning. The incidence of liver cancer has increased and it may explain some of the mortality. However, more work needs to be done to understand the reasons."
Dr. Kim says the study results are significant because an estimated 800,000 Americans have hepatitis B. "That number is likely an under-representation," he says. "In some U.S. immigrant communities, which often are excluded in disease tracking national surveys, the hepatitis B infection rate is 5 to 15 percent."
Those high numbers portend a continued high demand for liver transplants. In the United States, nearly 16,000 people are waiting for liver transplants.
Source: Mayo Clinic
- Transplanted fatty livers associated with worse prognosis for patients with HCVTue, 13 Jan 2009, 13:36:05 EST
- Racial disparity studied in patients undergoing liver transplantation for hepatitis BSat, 29 Aug 2009, 5:01:45 EDT
- IL28B gene predicts treatment outcome for liver transplantation patientsWed, 2 Mar 2011, 10:35:43 EST
- Liver transplant recipients with hepatitis B may need lifelong antiviral treatmentThu, 26 Feb 2009, 13:09:27 EST
- NewYork-Presbyterian/Columbia physician-scientists present at 2009 American Transplant CongressThu, 4 Jun 2009, 17:43:43 EDT
Articles on the same topic
- Study shows liver transplant center impacts patient outcomesSun, 2 May 2010, 19:52:12 EDT
- Extended hepatitis C treatment after liver transplant may benefit patientsSun, 2 May 2010, 9:33:01 EDT
- Extended hepatitis C treatment after liver transplant may benefit patientsfrom Science DailyThu, 6 May 2010, 2:31:27 EDT
- Some patients with hepatitis B faring better after liver transplantfrom Science CentricWed, 5 May 2010, 7:31:40 EDT
- Some patients with hepatitis B faring better after liver transplantfrom PhysorgWed, 5 May 2010, 5:50:39 EDT
- Study shows liver transplant center impacts patient outcomesfrom PhysorgMon, 3 May 2010, 6:41:33 EDT
- Extended hepatitis C treatment after liver transplant may benefit patientsfrom Science CentricMon, 3 May 2010, 5:20:51 EDT
- Study shows liver transplant centre impacts patient outcomesfrom Science CentricMon, 3 May 2010, 5:20:32 EDT
- Study shows liver transplant center impacts patient outcomesfrom Science BlogSun, 2 May 2010, 20:51:04 EDT
- Researchers make advances in understanding causes, treatments and outcomes of liver diseasefrom Science BlogSun, 2 May 2010, 15:20:24 EDT
- Extended hepatitis C treatment after liver transplant may benefit patientsfrom PhysorgSun, 2 May 2010, 13:51:15 EDT
- Extended hepatitis C treatment after liver transplant may benefit patientsfrom Science BlogSun, 2 May 2010, 9:31:02 EDT
Latest Science NewsletterGet the latest and most popular science news articles of the week in your Inbox! It's free!
Learn more about
Check out our next project, Biology.Net
From other science news sites
Popular science news articles
No popular news yet
- From ocean to land: The fishy origins of our hips
- New method of finding planets scores its first discovery
- Invasive crazy ants are displacing fire ants in areas throughout southeastern US
- Seabird bones reveal changes in open-ocean food chain
- Scientific insurgents say 'Journal Impact Factors' distort science
No popular news yet
No popular news yet
- Stem cell transplant restores memory, learning in mice
- 2 landmark studies report on success of using image-guided brachytherapy to treat cervical cancer
- Researchers discover mushrooms can provide as much vitamin D as supplements
- Cutting back on sleep harms blood vessel function and breathing control
- Study: Low-dose aspirin stymies proliferation of 2 breast cancer lines